Planning to submit NDA under accelerated approval pathway in H2 2025 based on existing clinical data, including results from BEACON and AURORA Phase 2 trials Achieved regulatory alignment on APOLLO ..
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback